• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生存素与结直肠癌的分子发病机制

Survivin and molecular pathogenesis of colorectal cancer.

作者信息

Kim Paul J, Plescia Janet, Clevers Hans, Fearon Eric R, Altieri Dario C

机构信息

Department of Cancer Biology and the Cancer Center, University of Massachusetts, Medical School, Worcester, MA, USA.

出版信息

Lancet. 2003 Jul 19;362(9379):205-9. doi: 10.1016/S0140-6736(03)13910-4.

DOI:10.1016/S0140-6736(03)13910-4
PMID:12885482
Abstract

BACKGROUND

Colorectal cancer is thought to originate in the expansion of colonic crypt cells as a result of aberrant gene expression caused by transcription factors of the T-cell factor (TCF)/beta-catenin family. Survivin is a bifunctional regulator of cell death and cell proliferation expressed during embryonic development but undetectable in healthy adult tissues and re-expressed in many cancers, including colorectal cancer.

METHODS

We investigated gene expression by promoter analysis, mutagenesis, and electrophoretic mobility shift assay in colorectal cancer cells. Survivin expression in human and mouse embryonic intestine was determined by in-situ hybridisation and immunohistochemistry. Changes in apoptosis were monitored in cell lines engineered to express stabilising mutations in beta catenin.

FINDINGS

TCF/beta catenin stimulated a six-fold to 12-fold increased expression of the survivin gene in colorectal cancer cells. Three TCF-binding elements (TBE) in the survivin promoter were occupied by nuclear factors in colorectal cancer cells, and mutagenesis of the two proximal TBE sites abolished survivin gene expression by 75-79%. Strongly expressed at the bottom of human and mouse embryonic intestinal crypts, expression of survivin was lost in TCF-4 knockout animals, and a TCF-4 dominant negative mutant blocked survivin gene transcription in colorectal cancer cells. Expression of non-destructible beta catenin mutants increased survivin expression and protected against ultraviolet-B-induced apoptosis.

INTERPRETATION

Stimulation of survivin expression by TCF/beta catenin might impose a stem cell-like phenotype to colonic crypt epithelium coupling enhanced cell proliferation with resistance to apoptosis, and contribute to the molecular pathogenesis of colorectal cancer.

摘要

背景

结直肠癌被认为起源于结肠隐窝细胞的扩增,这是由T细胞因子(TCF)/β-连环蛋白家族的转录因子引起的异常基因表达所致。存活素是一种细胞死亡和细胞增殖的双功能调节因子,在胚胎发育过程中表达,但在健康成人组织中无法检测到,而在包括结直肠癌在内的许多癌症中重新表达。

方法

我们通过启动子分析、诱变和电泳迁移率变动分析研究了结直肠癌细胞中的基因表达。通过原位杂交和免疫组织化学确定人及小鼠胚胎肠道中存活素的表达。在工程改造以表达β-连环蛋白稳定突变的细胞系中监测细胞凋亡的变化。

研究结果

TCF/β-连环蛋白刺激结直肠癌细胞中存活素基因的表达增加6至12倍。存活素启动子中的三个TCF结合元件(TBE)被结直肠癌细胞中的核因子占据,两个近端TBE位点的诱变使存活素基因表达减少75-79%。存活素在人及小鼠胚胎肠道隐窝底部强烈表达,在TCF-4基因敲除动物中存活素表达缺失,TCF-4显性负性突变体阻断结直肠癌细胞中存活素基因的转录。不可破坏的β-连环蛋白突变体的表达增加了存活素的表达,并保护细胞免受紫外线B诱导的凋亡。

解读

TCF/β-连环蛋白对存活素表达的刺激可能使结肠隐窝上皮具有干细胞样表型,将增强的细胞增殖与抗凋亡能力相结合,并有助于结直肠癌的分子发病机制。

相似文献

1
Survivin and molecular pathogenesis of colorectal cancer.生存素与结直肠癌的分子发病机制
Lancet. 2003 Jul 19;362(9379):205-9. doi: 10.1016/S0140-6736(03)13910-4.
2
Differential roles for the coactivators CBP and p300 on TCF/beta-catenin-mediated survivin gene expression.共激活因子CBP和p300在TCF/β-连环蛋白介导的生存素基因表达中的不同作用。
Oncogene. 2005 May 19;24(22):3619-31. doi: 10.1038/sj.onc.1208433.
3
[Indomethacin induces apoptosis through inhibition of survivin regulated by beta-catenin/TCF4 in human colorectal cancer cells].[吲哚美辛通过抑制β-连环蛋白/TCF4调控的生存素诱导人结肠癌细胞凋亡]
Ai Zheng. 2004 Jul;23(7):737-41.
4
Cdx1 inhibits human colon cancer cell proliferation by reducing beta-catenin/T-cell factor transcriptional activity.Cdx1通过降低β-连环蛋白/T细胞因子转录活性来抑制人结肠癌细胞增殖。
J Biol Chem. 2004 Aug 27;279(35):36865-75. doi: 10.1074/jbc.M405213200. Epub 2004 Jun 23.
5
Selection of multipotent stem cells during morphogenesis of small intestinal crypts of Lieberkuhn is perturbed by stimulation of Lef-1/beta-catenin signaling.在利伯库恩小肠隐窝形态发生过程中,多能干细胞的选择受到Lef-1/β-连环蛋白信号通路刺激的干扰。
J Biol Chem. 2002 May 3;277(18):15843-50. doi: 10.1074/jbc.M200184200. Epub 2002 Feb 19.
6
Casein kinase 2 (CK2) increases survivin expression via enhanced beta-catenin-T cell factor/lymphoid enhancer binding factor-dependent transcription.酪蛋白激酶2(CK2)通过增强β-连环蛋白-T细胞因子/淋巴细胞增强因子依赖性转录来增加生存素的表达。
Proc Natl Acad Sci U S A. 2006 Oct 10;103(41):15079-84. doi: 10.1073/pnas.0606845103. Epub 2006 Sep 27.
7
Indomethacin induces differential expression of beta-catenin, gamma-catenin and T-cell factor target genes in human colorectal cancer cells.吲哚美辛诱导人结肠癌细胞中β-连环蛋白、γ-连环蛋白和T细胞因子靶基因的差异表达。
Carcinogenesis. 2002 Jan;23(1):107-14. doi: 10.1093/carcin/23.1.107.
8
Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB.β-连环蛋白和TCF通过控制EphB/ephrinB的表达来介导肠上皮细胞的定位。
Cell. 2002 Oct 18;111(2):251-63. doi: 10.1016/s0092-8674(02)01015-2.
9
E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef-dependent transcription.通过减少β-连环蛋白-Tcf/Lef依赖性转录,E-钙黏蛋白是小窝蛋白-1介导的凋亡抑制蛋白survivin下调所必需的。
Mol Cell Biol. 2007 Nov;27(21):7703-17. doi: 10.1128/MCB.01991-06. Epub 2007 Sep 4.
10
Identification of BMP and activin membrane-bound inhibitor (BAMBI), an inhibitor of transforming growth factor-beta signaling, as a target of the beta-catenin pathway in colorectal tumor cells.鉴定骨形态发生蛋白和激活素膜结合抑制剂(BAMBI),一种转化生长因子-β信号通路的抑制剂,作为结直肠肿瘤细胞中β-连环蛋白通路的一个靶点。
J Biol Chem. 2004 Feb 20;279(8):6840-6. doi: 10.1074/jbc.M310876200. Epub 2003 Dec 1.

引用本文的文献

1
Computational and experimental discovery of peptide inhibitors targeting survivin for therapeutic potential in cancer.靶向生存素的肽抑制剂的计算与实验发现及其在癌症治疗中的潜力
Sci Rep. 2025 Aug 20;15(1):30599. doi: 10.1038/s41598-025-13110-3.
2
Glucocorticoid receptor-targeted liposomal delivery of wnt/β-catenin pathway inhibitor selectively induces efficient colorectal tumor regression.靶向糖皮质激素受体的脂质体递送Wnt/β-连环蛋白通路抑制剂可选择性诱导有效的结直肠癌消退。
Drug Deliv Transl Res. 2025 Aug 18. doi: 10.1007/s13346-025-01952-3.
3
USP36 inhibits apoptosis by deubiquitinating cIAP1 and survivin in colorectal cancer cells.
USP36 通过去泛素化 cIAP1 和 survivin 抑制结直肠癌细胞凋亡。
J Biol Chem. 2024 Jul;300(7):107463. doi: 10.1016/j.jbc.2024.107463. Epub 2024 Jun 12.
4
Anti-BIRC5 autoantibody serves as a valuable biomarker for diagnosing AFP-negative hepatocellular carcinoma.抗 BIRC5 自身抗体可作为诊断 AFP 阴性肝细胞癌的有价值的生物标志物。
PeerJ. 2024 May 31;12:e17494. doi: 10.7717/peerj.17494. eCollection 2024.
5
Survivin as a Therapeutic Target for the Treatment of Human Cancer.生存素作为治疗人类癌症的治疗靶点。
Cancers (Basel). 2024 Apr 27;16(9):1705. doi: 10.3390/cancers16091705.
6
Linderapyrone analogue LPD-01 as a cancer treatment agent by targeting importin7.林达泊龙类似物 LPD-01 通过靶向 Importin7 作为癌症治疗剂。
J Nat Med. 2024 Mar;78(2):370-381. doi: 10.1007/s11418-023-01774-y. Epub 2024 Jan 24.
7
Identification of the prognostic biomarkers and their correlations with immune infiltration in colorectal cancer through bioinformatics analysis and experiments.通过生物信息学分析和实验鉴定结直肠癌的预后生物标志物及其与免疫浸润的相关性。
Heliyon. 2023 Jun 12;9(6):e17101. doi: 10.1016/j.heliyon.2023.e17101. eCollection 2023 Jun.
8
3-Dimensional Model to Study Apoptosis Induction of Activated Natural Killer Cells Conditioned Medium Using Patient-Derived Colorectal Cancer Organoids.利用患者来源的结直肠癌类器官建立三维模型以研究活化自然杀伤细胞条件培养基诱导的细胞凋亡
Front Cell Dev Biol. 2022 May 26;10:895284. doi: 10.3389/fcell.2022.895284. eCollection 2022.
9
Intestinal Wnt in the transition from physiology to oncology.肠道Wnt在从生理到肿瘤学的转变过程中
World J Clin Oncol. 2022 Mar 24;13(3):168-185. doi: 10.5306/wjco.v13.i3.168.
10
The abnormal expression of chromosomal region maintenance 1 (CRM1)-survivin axis in ovarian cancer and its related mechanisms regulating proliferation and apoptosis of ovarian cancer cells.染色体区域维持 1(CRM1)-survivin 轴在卵巢癌中的异常表达及其调控卵巢癌细胞增殖和凋亡的相关机制。
Bioengineered. 2022 Jan;13(1):624-633. doi: 10.1080/21655979.2021.2012416.